Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are ...

Samsung Biologics has announced another significant manufacturing agreement, securing a $668m contract with a Europe-based ...

(RTTNews) - Samsung Bioepis Co., Ltd. and Biogen Inc. (BIIB) Monday announced that the European Commission (EC) has approved Opuviz, a biosimilar to Regeneron Pharmaceuticals' Aflibercept.

Biogen and Eisai’s Alzheimer’s disease (AD) drug has been recommended by the European Medicines Agency’s human medicines ...

In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Rhythm Pharmaceuticals (RYTM – Research Report), with a price ...

A handful of billion-dollar deals in the rare disease space highlights the uptick in Big Pharma’s investment, but it’s still ...

Following US approval in May this year, South Korea’s Samsung Bioepis and US biotech Biogen have now won approval from the ...

The European Commission grants marketing authorization to 2 aflibercept biosimilars; Biosimilars Canada launches new campaign ...

In September 2024, UCB and Biogen reported successful results from their Phase III clinical trial of the PHOENYCS GO study, which tested dapirolizumab pegol as a treatment for moderate-to-severe ...

RFK Jr.’s main claim to fame, apart from his ancestry, is from saying crazy things about vaccines. As has been well-documented, vaccines have not led to ...

As a pioneer in RNA-based treatments, Ionis Pharmaceuticals, Inc. (NASDAQ:IONS)’ Spinraza, a medication for spinal muscular ...

How is QQQ stock faring? The Invesco QQQ ETF is up 1.25% in the past five days and has risen about 23.47% year-to-date.